Synthesis and evaluation of a novel 2-azabicyclo[2.2.2]octane class of long chain fatty acid elongase 6 (ELOVL6) inhibitors

被引：3

作者：

Sasaki, Takahide ^{[1
]}

Nagase, Tsuyoshi ^{[1
]}

Takahashi, Toshiyuki ^{[1
]}

Nagumo, Akira ^{[1
]}

Shimamura, Ken ^{[1
]}

Miyamoto, Yasuhisa ^{[1
]}

Kitazawa, Hidefumi ^{[1
]}

Kanesaka, Maki ^{[1
]}

Yoshimoto, Ryo ^{[1
]}

Aragane, Katsumi ^{[1
]}

Tokita, Shigeru ^{[1
]}

Sato, Nagaaki ^{[1
,2
]}

机构：

[1] Banyu Pharmaceut Co Ltd, Merck Res Labs, Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan

[2] Taisho Pharmaceut Co Ltd, Taisho Res Labs, Kita Ku, Saitama 3319530, Japan

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2009年 / 17卷 / 15期

关键词：

Long chain fatty acid elongase 6 inhibitor; 2-Azabicyclo[2.2.2]octane; Anti-diabetic agent; Lipogenesis; ACYL-COA ELONGASE; ADIPOSE-TISSUE; GENE FAMILY; IDENTIFICATION; METABOLISM; CLONING;

D O I：

10.1016/j.bmc.2009.06.042

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of novel 2-azabicyclo[2.2.2]octane derivatives was synthesized and evaluated as long chain fatty acid elongase 6 (ELOVL6) inhibitors. Screening of our corporate chemical collections against ELOVL6 resulted in the identification of lead 1. Exploratory chemistry efforts were applied to lead 1 to identify the orally available, potent, and selective ELOVL6 inhibitor 28a. (C) 2009 Elsevier Ltd. All rights reserved.

引用

页码：5639 / 5647

页数：9

共 50 条

[41] RIGID ANALOGS OF DOPAMINE - SYNTHESIS AND INTERACTION OF 6-EXO- AND 6-ENDO-(3',4'-DIHYDROXYPHENYL)-2-AZABICYCLO[2.2.2]OCTANES WITH DOPAMINE UPTAKE SITES AND RECEPTORS
LAW, SJ
MORGAN, JM
MASTEN, LW
BORNE, RF
ARANA, GW
KULA, NS
BALDESSARINI, RJ
JOURNAL OF MEDICINAL CHEMISTRY, 1982, 25 (03) : 213 - 216
[42] Role of very long chain fatty acid elongase 2 (Elovl2) in the regulation of pancreatic beta cell dysfunction induced by gluco-lipotoxicity
Bellini, L.
Campana, M.
Machet, A.
Veret, J.
Chacinska, M.
Kassis, N.
Blachnio-Zabielska, A.
Ibberson, M.
Bernard, C.
Thorens, B.
Cruciani-Guglielmacci, C.
Magnan, C.
Le Stunff, H.
DIABETOLOGIA, 2015, 58 : S232 - S232
[43] Selective disruption of the very long chain fatty acid elongase 2 (ELOVL2) in the pancreatic beta cell impairs insulin release during obesity
Meneyrol, K.
Bellini, L.
Georgiadou, E.
Blondeau, B.
Kassis, N.
Thorens, B.
Rutter, G. A.
Cruciani-Guglielmacci, C.
Magnan, C.
Le Stunff, H.
DIABETOLOGIA, 2018, 61 : S198 - S198
[44] Synthesis of 6-Acetyl-1-methyl-3-oxo-5,8-diphenyl-2-azabicyclo[2.2.2]octane-4-carbonitrile
N. V. Nosova
A. V. Vagapov
P. A. Slepukhin
V. L. Gein
Chemistry of Heterocyclic Compounds, 2013, 48 : 1725 - 1727
[45] Synthesis of 6-Acetyl-1-methyl-3-oxo-5,8-diphenyl-2-azabicyclo[2.2.2]octane-4-carbonitrile
Nosova, N. V.
Vagapov, A. V.
Slepukhin, P. A.
Gein, V. L.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2013, 48 (11) : 1725 - 1727
[46] Tissue expression profiles and transcriptional regulation of elongase of very long chain fatty acid 6 in bovine mammary epithelial cells
Chen, Si
He, Hua
Liu, Xiaolin
PLOS ONE, 2017, 12 (04):
[47] CRYSTAL-STRUCTURE OF TRIMETHYL-DIBENZO[B,E]2-AZABICYCLO[2.2.2]OCTANE-2,3,3-CARBOXYLATE, C21H19NO6
KIRFEL, A
SCHWABENLANDER, F
HERDEIS, C
TROLL, A
ZEITSCHRIFT FUR KRISTALLOGRAPHIE, 1995, 210 (09): : 719 - 720
[48] SYNTHESIS OF THE SELECTIVE MUSCARINIC AGONIST (3R)-3-(6-CHLOROPYRAZIN-2-YL)-1-AZABICYCLO[2.2.2]OCTANE
ASHWOOD, MS
GIBSON, AW
HOUGHTON, PG
HUMPHREY, GR
ROBERTS, DC
WRIGHT, SHB
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1995, (06): : 641 - 644
[49] ELOVL6 promoter binding sites directly targeted by sterol regulatory element binding protein 1 in fatty acid synthesis of goat mammary epithelial cells
He, Qiuya
Luo, Jun
Wu, Jiao
Li, Zhuang
Yao, Weiwei
Zang, Saige
Niu, Huimin
JOURNAL OF DAIRY SCIENCE, 2021, 104 (05) : 6253 - 6266
[50] THE SYNTHESIS OF LONG CHAIN FATTY ACID DERIVATIVES OF THE VITAMIN-B6 GROUP
SAKURAGI, T
KUMMEROW, FA
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1956, 78 (04) : 839 - 842

← 1 2 3 4 5 →